Clinical Trial

Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal Carcinoma

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to compare chemotherapy plus immunotherapy with immunochemotherapy combined subsequent locoregional radiotherapy in recurrent nasopharyngeal carcinoma (NPC), in order to confirm the value of immunotherapy and chemotherapy in recurrent NPC patients.
Trial Details
NCT Number NCT07088484
Lead Sponsor Fujian Cancer Hospital
Conditions Recurrent Nasopharyngeal Carcinoma
Enrollment 50 participants
Start Date 2025-08-01
Primary Completion 2027-09-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-28